2013 annual financial data
Alnylam Pharmaceuticals 2013 Financial results
Direct answer
Revenue was 47.17M USD.
Operating income was -92.94M USD and net income was -89.23M USD.
Operating cash flow was -68.66M USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47.17M USD
- Operating income
- -92.94M USD
- Net income
- -89.23M USD
- Operating cash flow
- -68.66M USD
Explore related company data
View all 2013 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Alnylam Pharmaceuticals financial years